Board of Advisors
Bacilligen has assembled a world-class team of science and business advisors in the areas of molecular genetics, cancer, infectious disease, vaccinology, clinical development, and agricultural biotechnology to advise Management in all aspects of the Company’s strategic direction.
(Advisors in Alphabetical Order)
Oren J. Cohen, M.D.
Oren J. Cohen, M.D. is Senior Vice President, Clinical Research Strategies for Quintiles Transnational Corporation, a global contract research organization with over 20,000 employees in 54 countries. Dr. Cohen is also a Consulting Professor of Medicine on the Infectious Diseases faculty at Duke University Medical Center. A magna cum laude graduate of Brandeis University, Dr. Cohen is also an Alpha Omega Alpha honors graduate of the Duke University School of Medicine. Dr. Cohen completed an internship and residency in Internal Medicine at the New York Hospital/Cornell University Medical Center, where he served as Assistant Chief Resident in 1989-1990; he received the Richard Bowman award for dedication to medicine in 1990. He served from 1990-1991 as Clinical Instructor in Medicine at the New York Hospital's AIDS treatment center. Dr. Cohen completed his fellowship in Infectious Diseases in 1994 at the National Institute of Allergy and Infectious Diseases (NIAID), and spent seven years conducting basic and clinical HIV/AIDS research as a Fellow, Clinical Associate, and Medical Officer in the NIAID Laboratory of Immunoregulation. Dr. Cohen was appointed Assistant Director for Medical Affairs at NIAID, where he also served on the Department of Health and Human Services/Henry J. Kaiser Family Foundation Panel on Clinical Practices for the Treatment of HIV Infection, which formulates the national Guidelines for the Use of Antiretroviral Agents. Dr. Cohen joined Quintiles as a medical advisor in 2001, and served as Chief Medical and Scientific Officer from 2004-2008. Dr. Cohen is board-certified in Infectious Diseases and Internal Medicine and is a Fellow of the Infectious Diseases Society of America.
Roy Curtiss, III, Ph.D.
Dr. Roy Curtiss, III is a Professor of Life Sciences in the School of Life Sciences and Co-Director of the Center for Infectious Diseases and Vaccinology in the Biodesign Institute at Arizona State University. He recently left Washington University in St. Louis where he was the George William and Irene Koechig Freiberg Professor of Biology and was formerly Chairman of the Department and Professor of Cellular and Molecular Biology in the School of Dental Medicine. Dr. Curtiss currently has a lifetime appointment as the George William and Irene Koechig Freiberg Professor of Biology Emeritus. He received his BS from Cornell University and Ph.D. in Microbiology from the University of Chicago. He served as Biologist and Group Leader in the Biology Division at Oak Ridge National Laboratory, Professor, Associate Director and Interim Director of the University of Tennessee-Oak Ridge Graduate School of Biomedical Sciences, and Charles H. McCauley Professor of Microbiology at the University of Alabama in Birmingham. There he was Founder (1973) and Director (until 1983) of the NIH- and NSF-funded multidisciplinary and multiple departmental Molecular Cell Biology Graduate Program and also Founder (1980) and Director (until 1983) of the first Cystic Fibrosis Research Center at a US university. He is a Fellow of the American Academy of Microbiology, the American Association for the Advancement of Science, the St. Louis Academy of Sciences, and the Arizona Arts, Sciences and Technology Academy and is a member of the National Academy of Sciences.
Stanton L. Gerson, M.D.
Stanton [Stan] L Gerson, M.D. is the Asa and Patricia Shiverick- Jane Shiverick (Tripp) Professor of Hematological Oncology, Director NCI-designated Case Comprehensive Cancer Center and founding Director of the Ohio Wright Center for Stem Cell and Regenerative Medicine. He was Chief of the Division of Hematology/Oncology from 1995-2004 at University Hospitals of Cleveland and Case Western Reserve University. Dr. Gerson graduated from Harvard College [magna cum laude] and Harvard Medical School [cum laude] and performed his residency and fellowship training at the Hospital of the University of Pennsylvania. He has been at Case Western Reserve University since 1983 and has been active in the stem cell, hematologic malignancies and developmental therapeutics programs. He has multiple NIH grants and over 170 publications, 190 abstracts, 20 book chapters and seven patents in stem cells and drug discovery. His honors include invited membership in the American Association of Physicians, and the Malinkrodt Scholar award. Dr. Gerson is co-editor of the textbook Cancer Gene Therapy and Clinical Hematology. He serves on a number of Scientific Advisory Boards including the Fox Chase Cancer Center, the MD Anderson Cancer Center, the University of Minnesota Cancer Center and the Duke Cancer Center. Dr. Gerson has served as the Chair of the Experimental Therapeutics II and serves on the Program Project Study Section for the National Institutes of Health and on numerous other review bodies for the NIH.